New Drugs Approved in the USA 2018




59 novel drugs were approved in the USA in 2018, representing a leap from the 46 approved in 2017 and 22 approved in 2016.

19 of the 59 drugs (32 percent) have been designated ‘first-in-class’ and 34 of the 59 drugs (58 percent) were approved to treat rare or “orphan” diseases.

Additionally, GW Pharma’s Epidiolex represented the first FDA-approved drug derived from marijuana.

Continue at:

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:


Manostaxx – Industrial Management Consulting

Leave a Reply

Your email address will not be published. Required fields are marked *